Discussion revolved around understanding the risks and benefits of transitioning to the cloud for pharma and healthcare companies
REAN Cloud, a Premier Consulting Partner in the AWS Partner Network (APN) and AWS Life Sciences Partner, celebrated Healthcare and Pharma Enterprise Modernization week, June 7 to 9, 2016. During this week, REAN along with Dun & Bradstreet hosted a series of CIO Roundtable events in Hyderabad and Mumbai where pharma and healthcare industry leaders came together to share key insights about how cloud can help organisations become agile and responsive to quickly changing market, thereby paving way for greater innovation while reducing the burden of IT infrastructure cost.
The two CIO roundtables with focus on pharma and healthcare sector were hosted on June 7 at Taj Deccan, Hyderabad and on June 9 at Four Seasons, Mumbai. The theme for the events was Role of cloud computing in driving agility and flexibility in the pharma/healthcare sector. We had participation from the top pharma and healthcare companies including:
Dr Reddy’s Labs
Wockhardt Hospitals
Reliance Life Sciences
Biological E
US Pharmacopeia
Discussion revolved around understanding the risks and benefits of transitioning to the cloud for pharma and healthcare companies. The attendees acknowledged that while the use of cloud for regulated workloads is growing rapidly in the US and European markets with Amazon Web Services (AWS) providing the most compliant and secure environment for the pharma/healthcare sector; the cloud adoption in this industry is still at a nascent stage in the Indian market. The overarching view from the panel and participants alike was that there is no reason for the Indian market not to embrace the cloud capabilities and leverage the path paved by their US and European counterparts and to not only break the barriers for entry but enhance their innovation quotient.
Participants discussed data security on the cloud and custom cloud offerings for regulated workloads with regard to the pharma and healthcare sector. Many pharma industry leaders presented various present and future scenarios that could be made possible only on cloud and looked for guidance from technology partners such as AWS and REAN Cloud.
Sean Finnerty, Executive Director, Healthcare and Life Sciences, REAN Cloud, presented many interesting use-cases where AWS cloud has helped global pharma and life sciences giants to move complex applications like drug research, DNA sequencing, and clinical trials to the cloud while bringing down cost considerably and improving their go-to-market time.
Industry leaders concluded that the cloud drives innovation, can turn capex to opex, while meeting all government regulations and providing transparency in the business processes.
- Advertisement -
Comments are closed.